PPT-Role of Naloxone for Pharmacists

John J Faragon Pharmacist HIV Medicine Regional Pharmacy Director NYNJ AIDS Education and Training Center Objectives Describe the correlation between prescription drug abuse and the rate of opioid related overdose deaths . O. verdose Prevention Within an Addiction Treatment Program. Neil A. Capretto, D.O., F.A.S.A.M.. Medical . Director. Conflict of Interest . Statement:. Dr. Capretto has no fiduciary or other conflicts of interest to disclose. for Peace Officers and EMTs . Objectives . Background & statutes . Define naloxone . Routes of administration . Training requirements . Immunity . The Opioid Problem: . Lethal Drug. overdose. is the leading cause of . Catherine Borella Chemistry BA Class of 2016. Senior Chemistry Seminar . University of New Hampshire, Durham, NH, USA. Discussions. How the Government is Mandating Naloxone. Monte-Carlo (MC) Simulation Approach . PharmD/MBA 2016 . Oct. 6, 2015 the CDC recognized pharmacists and the . APhA. for their role . Pharmacists reduce barriers to getting vaccines in a way that other members of immunization cannot because of their locations and hours . Intranasal Administration of Naloxone for Suspected Opiate Overdose. Objectives. Overview of the problem . HB 965. What is an Opiate. Abuse. Side effects. Overdose indicators. What is Naloxone (. Narcan. Aaron Kochar, J.D.. akochar@yahoo.com. Talk Takeaways. Indiana’s legal framework has been revised to promote widespread distribution of naloxone to all Hoosiers. Indiana Laws written to remove barriers. Law Enforcement. There may be a title here that come from the foundation. Objectives . In this slide set, you will learn:. What naloxone (. Narcan. ) is. How it works when administered to a person who has overdosed. Findings from a linked dataset. Dan Galanis, Ph.D.. Epidemiologist. EMS & Injury Prevention System Branch. Hawaii Department of Health. 2. Overview of presentation. Part 1: EMS administration of naloxone (2012-2016). Adapted from: . Community . Access . Naloxone Is . there a downside. ?. . Michael . W. Dailey, MD . Albancy. Medical Center. Motor vehicle traffic, poisoning, drug poisoning, and unintentional drug poisoning death rates: United States, 1999--2010. Clinical . Professor of. Pharmacy. Practice. University of Rhode Island College of Pharmacy. . Implementing Naloxone Rescue Kits for Opioid . Overdose: . the Rhode . IsLanD. pharmacy experience . 1. Apply . Katherine Wang, . Pharm.D. .. The Center for Children and Women – . Greenspoint. Conflict of Interest Disclosure. The presenters, planners, reviewers (including CME administrator) of today’s CME activity do not have any financial relationships or commercial interests to disclose. Legislative and Regulatory Update. Nancy A. Alvarez, PharmD, BCPS, . FAPhA. President - 2017-2018. American Pharmacists Association. MPA Sesquicentennial Meeting. Oct. 14, 2017. Nancy A. Alvarez declares no conflicts of interest, real or apparent, and no financial interests in any company, product, or service mentioned in this program, including grants, employment, gifts, stock holdings, and honoraria. BUPRENORPHINE NALOXONE BNM Sublingual Tablets Buprenorphine Hydrochloride Naloxone Hydrochloride Consumer Medicine Information What is in this leaflet Please read this leaflet carefully before you are Trainer Name. location AND DATE. Learning objectives. By the end of the presentation, participants will:. Understand requirements of the Community-Based Naloxone Access Program Standing Order. Know what naloxone is and how to store, track and administer it.